Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-26-079635
Filing Date
2026-07-20
Accepted
2026-07-20 16:26:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 425 ea0298604-425_inmed.htm 425 26738
2 GRAPHIC ea029860401_img1.jpg GRAPHIC 183761
  Complete submission text file 0001213900-26-079635.txt   270114
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Filed by) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Subject) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 425 | Act: 34 | File No.: 001-39685 | Film No.: 261187075
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)